PA
CLGN icon

Parallel Advisors’s CollPlant Biotechnologies CLGN Stock Holding History

Parallel Advisors’s Portfolio CLGN Stock Details CLGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25 Hold
7
– – ﹤0.01% 3906
2026
Q1 		$38 Sell
7
-318
-98% -$3.21K ﹤0.01% 3800
2025
Q4 		$4.55K Hold
325
– – ﹤0.01% 2879
2025
Q3 		$8.75K Hold
325
– – ﹤0.01% 2576
2025
Q2 		$4.42K Hold
325
– – ﹤0.01% 2786
2025
Q1 		$8.39K Hold
325
– – ﹤0.01% 2502
2024
Q4 		$11.7K Hold
325
– – ﹤0.01% 2361
2024
Q3 		$16.2K Hold
325
– – ﹤0.01% 2201
2024
Q2 		$16.2K Sell
325
-83
-20% -$4.6K ﹤0.01% 2098
2024
Q1 		$21.8K Buy
408
+401
+5,729% +$21.7K ﹤0.01% 1931
2023
Q4 		$454 Sell
7
-849
-99% -$46.4K ﹤0.01% 3071
2023
Q3 		$47.7K Sell
856
-105
-11% -$6.95K ﹤0.01% 1418
2023
Q2 		$78.5K Hold
961
– – ﹤0.01% 1187
2023
Q1 		$67.5K Sell
961
-303
-24% -$29.7K ﹤0.01% 1226
2022
Q4 		$106K Sell
1,264
-374
-23% -$25.6K ﹤0.01% 970
2022
Q3 		$111K Hold
1,638
– – 0.01% 921
2022
Q2 		$131K Hold
1,638
– – 0.01% 857
2022
Q1 		$192K Sell
1,638
-369
-18% -$40.6K 0.01% 750
2021
Q4 		$328K Sell
2,007
-122
-6% -$21.8K 0.01% 577
2021
Q3 		$360K Buy
2,129
+1,699
+395% +$305K 0.01% 505
2021
Q2 		$91K Sell
430
-82
-16% -$13.1K ﹤0.01% 981
2021
Q1 		$69K Buy
512
+193
+61% +$29.1K ﹤0.01% 1035
2020
Q4 		$34K Buy
+319
New +$25.8K ﹤0.01% 1254

Other funds holding CLGN

PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $838M AUM 14.24% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
LWMI
Legacy Wealth Management (Idaho) Boise, Idaho $243M AUM 8.27% 1-Year Est. Return
WPC
Waters Parkerson & Co New Orleans, Louisiana $2.03B AUM 17.65% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Parallel Advisors's CLGN Position: Q2 2026 in Review

Parallel Advisors held its CollPlant Biotechnologies (CLGN) position steady in Q2 2026 at 7 shares worth $25. The position accounts for ﹤0.01% of the portfolio, ranked #3906.

Parallel Advisors first reported a position in CLGN in Q4 2020 and has held it in 23 quarters since. The position peaked at $360K in Q3 2021. 15 funds tracked by Wall St. Rank hold CLGN as of Q2 2026.

  • Parallel Advisors held 7 shares of CollPlant Biotechnologies worth $25 as of Q2 2026.
  • Parallel Advisors left its CollPlant Biotechnologies share count unchanged in Q2 2026.
  • CollPlant Biotechnologies made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3906 holding.
  • Parallel Advisors first reported a position in CollPlant Biotechnologies in Q4 2020 and has held it in 23 quarters since.
  • Parallel Advisors's CollPlant Biotechnologies position peaked at $360K in Q3 2021.
  • 15 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.